https://www.selleckchem.com/pr....oducts/a-d-glucose-a
ential of MR-guided liver SBRT and to identify which patients profit most from this new versatiletechnology. MR-guided SBRT of liver tumors is a well-tolerated and well-accepted treatment modality. Initial results are promising with excellent local control and only mildest toxicity. However, prospective studies are warranted to truly assess the potential of MR-guided liver SBRT and to identify which patients profit most from this new versatile technology. To determine if the new transrectal ultrasound (TRUS) techniques and